recommending management strategies for patients with colorectal cancer (crc) and other selected gastrointestinal cancers.
Terms of ReferenceThe participants in the 2010 Eastern Canadian Colorectal Cancer Consensus Conference consisted of oncology professionals from across Ontario, Quebec, and the Atlantic provinces. A few invited participants also came from Western Canada.The target audience for the present report is primarily health care professionals involved in the care of patients with crc and other selected gastrointestinal cancers. The report is intended to provide information about standards of care to administrators responsible for program funding decisions and to key players in the implementation of best practices. While not specifically targeted to patients, this report also provides information that may be useful in guiding patients who must make decisions about their own care.
Basis of RecommendationsThe recommendations provided here are based on presentation and discussion of the best available evidence. Where applicable, references are cited.These levels of evidence were used in the presentations 2 :• i: Evidence from randomized controlled trials • ii-1: Evidence from controlled trials without randomization
ABSTRACTThe annual Eastern Canadian Colorectal Cancer Consensus Conference was held in Ottawa, Ontario, October 22-23, 2010. Health care professionals involved in the care of patients with colorectal cancer participated in presentation and discussion sessions for the purpose of developing the recommendations presented here. This consensus statement addresses current issues in the management of colorectal cancer, such as the use of epidermal growth factor inhibitors in metastatic colon cancer, the benefit of calcium and magnesium with oxaliplatin chemotherapy, the role of microsatellites in treatment decisions for stage ii colon cancer, the staging and treatment of rectal cancer, and the management of colorectal and metastatic pancreatic cancers.